UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
NKTR holding history
Nektar Therapeutics in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q4 2025 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −1,328−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q1 2025 | 19,923 | $13.5K | <0.1% | −1,560,993−98.7% | Reduced | Holders |
| Q4 2024 | 1,580,916 | $1.47M | <0.1% | +430,087+37.4% | Added | Holders |
| Q3 2024 | 1,150,829 | $1.50M | <0.1% | +106,899+10.2% | Added | Holders |
| Q2 2024 | 1,043,930 | $1.29M | <0.1% | +108,310+11.6% | Added | Holders |
| Q1 2024 | 935,620 | $874.1K | <0.1% | −315,122−25.2% | Reduced | Holders |
| Q4 2023 | 1,250,742 | $706.7K | <0.1% | −125,507−9.1% | Reduced | Holders |
| Q3 2023 | 1,376,249 | $820.2K | <0.1% | +1,376,249 | New | Holders |